These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21177113)

  • 21. Lu-177 preparation for radiotherapy application.
    Park UJ; Lee JS; Choi KH; Nam SS; Yu KH
    Appl Radiat Isot; 2016 Sep; 115():8-12. PubMed ID: 27295512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
    Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
    Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radionuclide impurities in proton-irradiated [18O]H2O for the production of 18F-: activities and distribution in the [18F]FDG synthesis process.
    Bowden L; Vintró LL; Mitchell PI; O'Donnell RG; Seymour AM; Duffy GJ
    Appl Radiat Isot; 2009 Feb; 67(2):248-55. PubMed ID: 19111472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
    Chen J; Linder KE; Cagnolini A; Metcalfe E; Raju N; Tweedle MF; Swenson RE
    Appl Radiat Isot; 2008 Apr; 66(4):497-505. PubMed ID: 18178448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of lutetium-177 production at the WWR-K research reactor.
    Sairanbayev D; Koltochnik S; Shaimerdenov A; Chakrova Y; Gurin A; Kenzhin Y
    Appl Radiat Isot; 2021 Mar; 169():109561. PubMed ID: 33360502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a 177Hf complex formed by beta-decay of a 177Lu-labeled radiotherapeutic compound and NMR structural elucidation of the ligand and its Lu and Hf complexes.
    Cagnolini A; D'Amelio N; Metcalfe E; Nguyen HD; Aime S; Swenson RE; Linder KE
    Inorg Chem; 2009 Apr; 48(7):3114-24. PubMed ID: 19243162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
    Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
    J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A strategy for intensive production of molybdenum-99 isotopes for nuclear medicine using CANDU reactors.
    Morreale AC; Novog DR; Luxat JC
    Appl Radiat Isot; 2012 Jan; 70(1):20-34. PubMed ID: 21816619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
    Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of 61Cu using natural cobalt target and its separation using ascorbic acid and common anion exchange resin.
    Das SS; Chattopadhyay S; Barua L; Das MK
    Appl Radiat Isot; 2012 Feb; 70(2):365-8. PubMed ID: 22093183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.
    Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
    Appl Radiat Isot; 2008 Sep; 66(9):1196-205. PubMed ID: 18372188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indirect Production of No Carrier Added (NCA) (177)Lu from Irradiation of Enriched (176)Yb: Options for Ytterbium/Lutetium Separation.
    Dash A; Chakravarty R; Knapp FF; Pillai AM
    Curr Radiopharm; 2015; 8(2):107-18. PubMed ID: 25771377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production and characterization of
    Morselli L; Donzella A; Arzenton A; Asti M; Bortolussi S; Corradetti S; D'Agostino G; Di Luzio M; Ferrari M; Gandini A; Lunardon M; Villa V; Salvini A; Zangrando L; Zenoni A; Andrighetto A
    Appl Radiat Isot; 2023 Jul; 197():110798. PubMed ID: 37028101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
    Mulligan T; Carrasquillo JA; Chung Y; Milenic DE; Schlom J; Feuerstein I; Paik C; Perentesis P; Reynolds J; Curt G
    Clin Cancer Res; 1995 Dec; 1(12):1447-54. PubMed ID: 9815943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific radioactivity of neutron induced radioisotopes: assessment methods and application for medically useful 177Lu production as a case.
    Le VS
    Molecules; 2011 Jan; 16(1):818-46. PubMed ID: 21248665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-targeting properties of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model.
    Miao Y; Hoffman TJ; Quinn TP
    Nucl Med Biol; 2005 Jul; 32(5):485-93. PubMed ID: 15982579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complexes of low energy beta emitters 47Sc and 177Lu with zoledronic acid for bone pain therapy.
    Majkowska A; Neves M; Antunes I; Bilewicz A
    Appl Radiat Isot; 2009 Jan; 67(1):11-3. PubMed ID: 18929490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental study and nuclear model calculations on the 192Os(p,n)192Ir reaction: Comparison of reactor and cyclotron production of the therapeutic radionuclide 192Ir.
    Hilgers K; Sudár S; Qaim SM
    Appl Radiat Isot; 2005 Jul; 63(1):93-8. PubMed ID: 15866453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.